Zealand Pharma to Participate in Upcoming Investor Conferences
08 Novembro 2022 - 10:30AM
Company announcement – No. 50 / 2022
Zealand Pharma to Participate in
Upcoming Investor Conferences
Copenhagen, Denmark and Boston, MA, U.S. November 8,
2022 – a Zealand Pharma A/S (CVR-no. 20045078) a
biotechnology company focused on the discovery and development of
innovative peptide-based medicines, today announced that the
company is scheduled to participate in the following investor
conferences in November:
Jefferies London Healthcare ConferenceDate: Tuesday, November
15, 2022Presentation: 3:35 a.m. EST / 8:35 a.m. GMT / 9:35 a.m.
CET
Evercore ISI Annual HealthCONx Conference (virtual)Date:
Tuesday, November 29, 2022Presentation: 9:40 a.m. EST / 2:40 p.m.
GMT / 3:40 p.m. CET
A live webcast of the presentations will be available on the
"Events & Presentations" page in the Investor section of the
Company's website at
https://www.zealandpharma.com/events-presentations. A replay of the
webcast will be archived on the Company's website following the
presentation.
About Zealand Pharma A/SZealand Pharma A/S
(Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on
the discovery and development of peptide-based medicines. More than
10 drug candidates invented by Zealand have advanced into clinical
development, of which two have reached the market and three
candidates are in late-stage development. In addition, license
collaborations with Boehringer Ingelheim and AstraZeneca create
opportunities for more patients to potentially benefit from
Zealand-invented peptide investigational agents currently in
development.
Zealand was founded in 1998 and headquartered in Copenhagen,
Denmark, with a presence in the U.S. that includes Boston. For more
information about Zealand’s business and activities, please
visit http://www.zealandpharma.com.
Contacts:Anna
Krassowska, PhDVice President, Investor Relations & Corporate
CommunicationsZealand PharmaEmail: ank@zealandpharma.com
David Rosen (U.S. Media)Argot PartnersEmail:
media@zealandpharma.com
Zealand Pharma AS (NASDAQ:ZEAL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zealand Pharma AS (NASDAQ:ZEAL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
